CellSource To Apply For Transition To TSE Standard Market Following Weak Performance

MT Newswires Live

Jan 28

CellSource (TYO:4880) said that its board has resolved to apply for a move from the Tokyo Stock Exchange Prime Market to the Standard Market, according to a Wednesday filing on the Tokyo Stock Exchange.

The Japanese regenerative medicine-related company shifted to the Prime Market in October 2023 to support the industrialization of its business. However, weak performance in the fiscal year ended Oct. 31, 2025, left the company below the "market capitalization of tradable shares of 10 billion yen or more" required to remain in the Prime Market.

CellSource said the Standard Market, which maintains governance and liquidity standards, is more suitable given its current business scale and market conditions. The date of approval is undecided, and the company's application may not be accepted if listing requirements are not met.

As of Oct. 31, 2025, the company said it meets all criteria for the Standard Market, including shareholder numbers, tradable shares, and tradable share ratio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606945793"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606945793\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606945793?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 15:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606945793","market":"sg","top_or_hot":-1,"title":"CellSource To Apply For Transition To TSE Standard Market Following Weak Performance","media":"MT Newswires Live","content":"<html><body><p> CellSource (TYO:4880) said that its board has resolved to apply for a move from the Tokyo Stock Exchange Prime Market to the Standard Market, according to a Wednesday filing on the Tokyo Stock Exchange.</p><p>The Japanese regenerative medicine-related company shifted to the Prime Market in October 2023 to support the industrialization of its business. However, weak performance in the fiscal year ended Oct. 31, 2025, left the company below the \"market capitalization of tradable shares of 10 billion yen or more\" required to remain in the Prime Market.</p><p>CellSource said the Standard Market, which maintains governance and liquidity standards, is more suitable given its current business scale and market conditions. The date of approval is undecided, and the company's application may not be accepted if listing requirements are not met.</p><p>As of Oct. 31, 2025, the company said it meets all criteria for the Standard Market, including shareholder numbers, tradable shares, and tradable share ratio.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CellSource To Apply For Transition To TSE Standard Market Following Weak Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellSource To Apply For Transition To TSE Standard Market Following Weak Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-28 15:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> CellSource (TYO:4880) said that its board has resolved to apply for a move from the Tokyo Stock Exchange Prime Market to the Standard Market, according to a Wednesday filing on the Tokyo Stock Exchange.</p><p>The Japanese regenerative medicine-related company shifted to the Prime Market in October 2023 to support the industrialization of its business. However, weak performance in the fiscal year ended Oct. 31, 2025, left the company below the \"market capitalization of tradable shares of 10 billion yen or more\" required to remain in the Prime Market.</p><p>CellSource said the Standard Market, which maintains governance and liquidity standards, is more suitable given its current business scale and market conditions. The date of approval is undecided, and the company's application may not be accepted if listing requirements are not met.</p><p>As of Oct. 31, 2025, the company said it meets all criteria for the Standard Market, including shareholder numbers, tradable shares, and tradable share ratio.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMP","symbol_name":"Standard Motor Products Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2606945793","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606945793","pubTimestamp":1769586891,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"CellSource  said that its board has resolved to apply for a move from the Tokyo Stock Exchange Prime Market to the Standard Market, according to a Wednesday filing on the Tokyo Stock Exchange.The Japanese regenerative medicine-related company shifted to the Prime Market in October 2023 to support the industrialization of its business. However, weak performance in the fiscal year ended Oct. 31, 2025, left the company below the \"market capitalization of tradable shares of 10 billion yen or more\" required to remain in the Prime Market.CellSource said the Standard Market, which maintains governance and liquidity standards, is more suitable given its current business scale and market conditions. The date of approval is undecided, and the company's application may not be accepted if listing requirements are not met.As of Oct. 31, 2025, the company said it meets all criteria for the Standard Market, including shareholder numbers, tradable shares, and tradable share ratio.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SMP":"Standard Motor Products Inc","TSE":"Trinseo","BK4124":"机动车零配件与设备","BK4090":"商品化工"},"translate_title":"业绩疲软后CellSource将申请过渡到东京证交所标准市场","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSE":1.5,"SMP":1.5},"content_text":"CellSource (TYO:4880) said that its board has resolved to apply for a move from the Tokyo Stock Exchange Prime Market to the Standard Market, according to a Wednesday filing on the Tokyo Stock Exchange.The Japanese regenerative medicine-related company shifted to the Prime Market in October 2023 to support the industrialization of its business. However, weak performance in the fiscal year ended Oct. 31, 2025, left the company below the \"market capitalization of tradable shares of 10 billion yen or more\" required to remain in the Prime Market.CellSource said the Standard Market, which maintains governance and liquidity standards, is more suitable given its current business scale and market conditions. The date of approval is undecided, and the company's application may not be accepted if listing requirements are not met.As of Oct. 31, 2025, the company said it meets all criteria for the Standard Market, including shareholder numbers, tradable shares, and tradable share ratio.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}